Anna Hartwig

Anna Hartwig is an experienced research and development professional with a strong background in biomedicine, holding a Ph.D. and an M.Sc. from Karolinska Institutet. Currently serving as R&D Director at Natera since March 2025, Anna has previously held notable positions including VP of Product Technology Development at Exai Bio and Associate Director at Guardant Health, where leadership in assay development and high-performing team cultivation were key focuses. Anna's earlier roles at TOMA Biosciences and Yale University involved significant contributions to innovative product development and research on non-coding RNAs in cancer, showcasing a robust expertise in NGS technology and liquid biopsy assays.